LIAONING GREATEST BIO PHARMACEUTICAL CO LTD has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BENED BIOMEDICAL CO LTD, CAELUS PHARMACEUTICALS B V and INTREXON ACTOBIOTICS NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 14 | |
#3 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Microorganisms | |
#5 | Fermentation | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Dou Chunyan | 28 |
#2 | Zhang Guoying | 28 |
#3 | Zhang Yi | 28 |
#4 | Gai Bo | 25 |
#5 | Ge Bo | 5 |
#6 | Nan Ning | 2 |
#7 | Dou Heng | 2 |
#8 | Xu Yongmeng | 2 |
#9 | Shi Mingsheng | 2 |
#10 | Jian Zhao | 1 |
Publication | Filing date | Title |
---|---|---|
CN112135620A | Use of nocardia rubra cell wall skeleton in treatment of thermal injury | |
CN111971054A | Application of Rhodococcus ruber product in treating white lesions of vulva | |
CN111683670A | Use of nocardia rubra cell wall skeleton in treatment of recurrent aphthous ulcers | |
CN111727235A | Rhodococcus ruber product and pharmaceutical use thereof | |
WO2020143393A1 | Use of red nocardia cell wall skeleton for preparing pharmaceutical for treating lichen planus | |
CN108815197A | Lyopgized Nocardia rubra-cell Wall Skeleton is as CD4+The purposes of T cell enhancer of proliferation | |
CN108815198A | Purposes of the Lyopgized Nocardia rubra-cell Wall Skeleton as macrophage proliferation promotor | |
BRPI0520568A2 | Use of nubardia rubra cell wall skeleton for preparation of anti-hpv infection medicinal products |